Drug Policy Harmonization and the European Union PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Drug Policy Harmonization and the European Union PDF full book. Access full book title Drug Policy Harmonization and the European Union by C. Chatwin. Download full books in PDF and EPUB format.
Author: C. Chatwin
Publisher: Springer
ISBN: 0230306837
Category : Political Science
Languages : en
Pages : 192
Get Book Here
Book Description
Exploring the illegal drug issue in international context, this book looks at why harmonization has not already taken place at the European level. It considers the desirability and viability of harmonization, examines the conflict between repressive and liberal drug policies and applies a multi-level governance lens to the issue.
Author: C. Chatwin
Publisher: Springer
ISBN: 0230306837
Category : Political Science
Languages : en
Pages : 192
Get Book Here
Book Description
Exploring the illegal drug issue in international context, this book looks at why harmonization has not already taken place at the European level. It considers the desirability and viability of harmonization, examines the conflict between repressive and liberal drug policies and applies a multi-level governance lens to the issue.
Author: M. Elvins
Publisher: Springer
ISBN: 0230006167
Category : Political Science
Languages : en
Pages : 242
Get Book Here
Book Description
Martin Elvins' book is the first to trace the evolution of anti-drugs policies at European Union level from the late 1960s to the present. Phases of drug policy development, key policy actors and institutions are described with particular reference to the influence of transnational networks of expertise. Policy development is placed in the context of both European integration and a broad harmonization of international policies against drug trafficking. Concerns are also raised about secretive and anti-democratic features on intergovernmental EU decision-making.
Author: Mckee
Publisher: McGraw-Hill Education (UK)
ISBN: 0335226442
Category : Medical
Languages : en
Pages : 312
Get Book Here
Book Description
While there may be consensus on the broader issues of the core objectives of the health care system, expectations differ between EU countries, and European national policy-makers. This book seeks firstly to assess the impact of the enlargement process and then to analyse the challenges that lie ahead in the field of health and health policy.
Author: David R. Bewley-Taylor
Publisher: Edward Elgar Publishing
ISBN: 1788117069
Category : Social Science
Languages : en
Pages : 421
Get Book Here
Book Description
Analysing arguably one of the most controversial areas in public policy, this pioneering Research Handbook brings together contributions from expert researchers to provide a global overview of the shifting dynamics of drug policy. Emphasising connections between the domestic and the international, contributors illustrate the intersections between drug policy, human rights obligations and the 2030 Sustainable Development Agenda, offering an insightful analysis of the regional dynamics of drug control and the contemporary and emerging problems it is facing.
Author: Helena Legido-Quigley
Publisher: World Health Organization
ISBN: 9289071931
Category : Medical
Languages : en
Pages : 242
Get Book Here
Book Description
People have always travelled within Europe for work and leisure, although never before with the current intensity. Now, however, they are travelling for many other reasons, including the quest for key services such as health care. Whatever the reason for travelling, one question they ask is "If I fall ill, will the health care I receive be of a high standard?" This book examines, for the first time, the systems that have been put in place in all of the European Union's 27 Member States. The picture it paints is mixed. Some have well developed systems, setting standards based on the best available evidence, monitoring the care provided, and taking action where it falls short. Others need to overcome significant obstacles.
Author: Renaud Colson
Publisher: Routledge
ISBN: 1317426940
Category : Law
Languages : en
Pages : 369
Get Book Here
Book Description
The drug control regime established by the international community has not succeeded in curbing either the demand for, or the offer of, narcotics. But, despite a series of developments in the Americas – including the legalisation of cannabis in Uruguay and in several states in the United States of America – there is still little support in Europe for repealing drug-prohibition laws. Nevertheless, a gradual policy convergence reveals the emergence of a European model favouring public-health strategies over a strictly penal approach to combatting drugs, while growing transnational support for legalisation indicates the persistence of an alternative paradigm for drug policy. This book examines the various influences on drug policies in Europe, as grassroots movements, NGO networks, private foundations and academic research centres increasingly confront the prevailing discourses of drug prohibition. Pursuing an interdisciplinary approach and bringing together legal scholars, social scientists and practitioners, it provides a comprehensive and critical assessment of drug policy reform in Europe.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309212421
Category : Medical
Languages : en
Pages : 318
Get Book Here
Book Description
Medical devices that are deemed to have a moderate risk to patients generally cannot go on the market until they are cleared through the FDA 510(k) process. In recent years, individuals and organizations have expressed concern that the 510(k) process is neither making safe and effective devices available to patients nor promoting innovation in the medical-device industry. Several high-profile mass-media reports and consumer-protection groups have profiled recognized or potential problems with medical devices cleared through the 510(k) clearance process. The medical-device industry and some patients have asserted that the process has become too burdensome and is delaying or stalling the entry of important new medical devices to the market. At the request of the FDA, the Institute of Medicine (IOM) examined the 510(k) process. Medical Devices and the Public's Health examines the current 510(k) clearance process and whether it optimally protects patients and promotes innovation in support of public health. It also identifies legislative, regulatory, or administrative changes that will achieve the goals of the 510(k) clearance process. Medical Devices and the Public's Health recommends that the U.S. Food and Drug Administration gather the information needed to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices. According to the report, the FDA's finite resources are best invested in developing an integrated premarket and postmarket regulatory framework.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309498635
Category : Medical
Languages : en
Pages : 169
Get Book Here
Book Description
Globalization is rapidly changing lives and industries around the world. Drug development, authorization, and regulatory supervision have become international endeavors, with most medicines becoming global commodities. Drug companies utilize global supply chains that often include facilities in countries with inconsistent regulations from those of the United States, perform pivotal trials in multiple countries to support registration submissions in various jurisdictions, and subsequently market their medicines throughout most of the world. These companies operate across borders and require individual national regulators to ensure that drugs authorized for use in their countries are safe and effective, and appropriate for their health care system and their population. This process involves significant resources and often duplicative work. It is important to consider how this process can be improved in order to better allocate resources, time, and efforts to improve public health. Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators considers the role of mutual recognition and other reliance activities among regulators in contributing to enhancing public health. This report identifies opportunities for leveraging reliance activities more broadly in order to potentially impact public health globally. Key topics in this report include the job of medicines regulators in today's world, what policy makers need to know about today's regulatory environment, stakeholder views of recognition and reliance, as well as removing impediments and facilitating action for greater recognition and reliance among regulatory authorities.
Author: Helen Wallace
Publisher: Oxford University Press, USA
ISBN: 0199689679
Category : Political Science
Languages : en
Pages : 613
Get Book Here
Book Description
The policies of the European Union profoundly affect the lives of people in Europe and around the world. The new edition of this highly successful textbook outlines how and why such decisions are made, as well as the key challenges faced by policy-makers in the current political and economic climate.
Author: Caroline Chatwin
Publisher: Springer
ISBN: 3319920723
Category : Social Science
Languages : en
Pages : 245
Get Book Here
Book Description
This book examines the topical issue of global drug policy and outlines five steps that could be taken to improve its effectiveness. A public criminology approach is applied to explore not only what could be done, but also why it matters and how it could be achieved. It argues that more effective global drug policies require an acknowledgement of the failure of a war on drugs approach and the harms it has caused. Instead, strategies that reduce drug related harm should be prioritised. An innovative and diverse range of approaches should be developed that are underpinned by evaluation and dissemination of results. Finally, the horizons of the drug policy debate should be broadened. In line with the central aims of public criminology, this book provides an accessible contribution to global drug policy debates that links theory and practice and which will have appeal to a wide range of audiences.
